Distinct Epigenetic Alterations And Accelerated Mitotic Aging Define Second Primary Breast Cancers
For individuals who have successfully overcome cancer, the development of a new, unrelated tumor can be a challenging reality. Recent research sheds light on why these subsequent cancers, specifically in the breast, often behave more aggressively than initial tumors. The study reveals that these second primary breast cancers possess unique “epigenetic marks” – these are like tags on our DNA that tell genes when to turn on or off, without actually changing the underlying genetic code. These marks are distinct from those found in first-time breast cancers.
Furthermore, these tumors show signs of accelerated biological aging at a cellular level, meaning the cells appear older than their chronological age. This accelerated aging, combined with the specific epigenetic alterations, particularly in genes involved in how cells respond to hormones, may contribute to the poorer outcomes observed in patients with these secondary cancers. Researchers suggest that these molecular “scars” could be a consequence of the previous cancer, its treatments like chemotherapy or radiation, and the overall impact of accelerated biological aging. Understanding these fundamental differences is crucial for developing more effective and tailored treatment strategies for cancer survivors facing a new diagnosis.
Source: link to paper